Previous close | 123.50 |
Open | 129.08 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 123.30 - 130.00 |
52-week range | 74.70 - 140.32 |
Volume | |
Avg. volume | 41,906 |
Market cap | 568.923B |
Beta (5Y monthly) | 0.19 |
PE ratio (TTM) | 46.68 |
EPS (TTM) | 2.67 |
Earnings date | N/A |
Forward dividend & yield | 1.86 (1.49%) |
Ex-dividend date | 22 Mar 2024 |
1y target est | N/A |
Nvidia and several other leaders flashed buy signals as the market roared. Investors should take advantage, but it's a jungle out there.
Earnings preview of key companies reporting next week and what to look out for.
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk A/S as per the end of a month where changes therein have occurred. Referring to Company Announcement no 32/2024 dated 24 April 2024, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk A/S as per 26 April 2024. Number of